CARL L GORDON Insider Trading $ASNS X4 Pharmaceuticals, Inc
Get free email notifications about insider trading for CARL L GORDON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARL L GORDON. CARL L GORDON is Director in SELECTA BIOSCIENCES INC ($SELB) and Director in Arsanis, Inc. ($ASNS) and Director in Turning Point Therapeutics, Inc. ($TPTX) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in Alector, Inc. ($ALEC) and Director in Keros Therapeutics, Inc. ($KROS) and Director in ARMO BioSciences, Inc. ($ARMO) and Director in Adicet Bio, Inc. ($TORC) and Director in Prevail Therapeutics Inc. ($PRVL) and in Kinnate Biopharma Inc. ($KNTE) and Director in Oric Pharmaceuticals, Inc. ($ORIC) and Director in Terns Pharmaceuticals, Inc. ($TERN).
CARL L GORDON in X4 Pharmaceuticals, Inc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of CARL L GORDON: Director
Holdings: 19,533 shares
Latest Transaction: Jun 07 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CARL L GORDON in X4 Pharmaceuticals, Inc
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, TORC, ALEC, ARMO, NTLA, KROS, KNTE, ORIC, PRVL, SELB, TERN, TPTX, ASNS
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2018 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | A | 16.99 | 10,000 | 169,900 | 10,000 | |
| Dec 01 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | A | 10.00 | 7,324 | 73,240 | 7,324 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 2,232,014 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 229,412 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 736,648 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 704,846 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Option Exercise | C | 0.00 | 66,667 | 0 | 0 | |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,868,966 | 1.4 M to 1.9 M (+36.52 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 653,974 | 0 | 1,368,966 | 715 K to 1.4 M (+91.47 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 114,320 | 0 | 714,992 | 600.7 K to 715 K (+19.03 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 328,909 | 0 | 600,672 | 271.8 K to 600.7 K (+121.03 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 252,230 | 0 | 271,763 | 19.5 K to 271.8 K (+1,291.30 %) |
| Nov 20 2017 | ASNS | Arsanis, Inc. | GORDON CARL L | Director | Buy | C | 0.00 | 19,533 | 0 | 19,533 | 0 to 19.5 K |
Page: 1